In 1983, a trial began that would forever alter the standard of management of type 1 diabetes (T1D) and serve as a stepping stone to future research advances—and as we mark the 30th anniversary of the trial’s inception, we are still learning from the study.
Can Type 2 or Type 1 diabetes be not only reversed, but cured? Can beta cells start producing enough insulin? Can the liver store glucose better, and can body cells learn to handle glucose more efficiently?
Patients with type 2 diabetes who tailor their own treatment in cooperation with their doctor can reduce their risk of complications such as heart attack with up to 20 percent.
A recent study, observed the effects of high fat meals on glucose levels and insulin requirements in type 1 diabetics. The study incorporated seven patients with type 1 diabetes and an average age of 55 years old.
Researchers are focused on a type 1 diabetes cure, and one small study with a TB vaccine showed signs of hope.
In a study of patients with type 1 diabetes, Joslin researchers found that dietary fat can affect glucose levels and insulin requirements. These findings, which appeared in the April edition of Diabetes Care, have major implications for the management of type 1 diabetes.
Research into a cure for type 1 diabetes proceeds on several fronts. One interesting approach is seeking ways to manipulate the autoimmune system to prevent the body’s mistaken destruction of pancreatic beta cells.
The “reprogramming” of related alpha cells into beta cells may one day offer a novel and complementary approach for treating type 2 diabetes.
This year the Standards are largely similar to the recommendations published last year but there have been some changes in a few categories because of new evidence or a change in the strength of the evidence in the medical literature.
Researchers from the Universitat Aut-noma de Barcelona (UAB), led by F-tima Bosch, have shown for the first time that it is possible to cure diabetes in large animals with a single session of gene therapy.
Particularly for people with type 1 diabetes, who must test their own blood sugar throughout each day and inject insulin to regulate sugar levels, a cap on the number of test strips they’re allowed to use may seriously affect their health, researchers say.
Researchers have documented a startling rise in the rate of type 1 diabetes in one city: Diagnoses in kids younger than 5 jumped by 70 percent between 1985 and 2004 in Philadelphia.
As published this week in Diabetes, the principal journal for research on the disease, after a single gene therapy session, the dogs recover their health and no longer show symptoms of the disease. In some cases, monitoring continued for over four years, with no recurrence of symptoms.
They believe a vaccine can slow or stop the disease’s development and recently-diagnosed adult volunteers are being sought to take part in the trial.
Having adequate levels of vitamin D during young adulthood may reduce the risk of adult-onset type 1 diabetes by as much as 50%.
The pancreases of people with type 1 diabetes shrink, a study found, and this contraction probably starts even before the disease’s onset and continues as the years pass.
Medicare deputy administrator Jonathan Blum said Wednesday it’s due to competitive bidding making inroads against wasteful spending.
Minimally invasive islet transplantation for patients with type 1 diabetes achieves insulin independence and reverses the progression of atherosclerosis in the first few years after transplant, according to a University of Illinois at Chicago study.
In a trial of 12 patients with Type 1 diabetes, Biodel’s two formulations showed significantly more rapid absorption rates and declines from peak concentrations. Discomfort levels associated with BIOD-250 were comparable to Humalog, though those related to BIOD-238 were significantly higher.
Australian diabetes experts, psychiatrists and neuroscientists have reported the benefits of measuring depression and disease-related distress in patients with diabetes.